SCHEMBL222211

SCHEMBL222211

Cc1cc(N(C2CCN(C(C)C)CC2)S(=O)(=O)CCNC(=O)c2ccc(Cl)s2)no1

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.58
F2 P00734 1/20 0.38
KLK1 P06870 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220224 0.87 F10 (0.57) F10F2KLK1
SCHEMBL222823 0.84 F10 (0.59) F10F2MAPK1
SCHEMBL222531 0.83 F10 (0.60) F10MAPK1
SCHEMBL221193 0.81 F10 (0.69) F10MAPK1
SCHEMBL220475 0.80 F10 (0.67) F10MAPK1
SCHEMBL222060 0.79 F10 (0.55) F10F2KLK1
SCHEMBL222611 0.79 F10 (0.66) F10MAPK1
SCHEMBL2737094 0.78 F10 (0.63) F10MAPK1
SCHEMBL219860 0.78 F10 (0.65) F10MAPK1
SCHEMBL219872 0.77 F10 (0.63) F10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088925-B2 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents SANOFI-AVENTIS (FR) 2012-01-03 US disclosed